share_log

Marker Therapeutics Q3 EPS $(0.08) Up From $(0.15) YoY

Benzinga Real-time News ·  Nov 11, 2022 05:45

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.08) per share. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment